体部介入MRI:当前实践与未来展望
本文综述体部介入MRI的技术进展与临床应用。iMRI凭借软组织分辨率高、多平面成像及无电离辐射等优势,已用于疑难病灶定位、活检、硬化治疗及肿瘤消融。安全实施需介入放射科、MR物理师等多方协作,并严格管理MR III/IV区风险。
要点
- iMRI优势包括软组织分辨率高、多平面成像、无电离辐射及可重复同一层面成像。
- 临床应用涵盖疑难病灶定位、活检、硬化治疗及良恶性肿瘤冷冻与热消融。
- MR环境安全需团队协作,对人员和设备实施MR III/IV区风险限制措施。
核心结论
- 体部介入MRI临床应用已大幅扩展,适用于需MRI最佳显示病灶或需优质软组织对比监测治疗的场景。
- iMRI的优势包括软组织分辨率高、多平面成像便捷、无电离辐射及可重复同一层面成像。
- iMRI的不足包括检查时间较长、MR兼容设备缺乏、操作者熟悉度较低及成本增加。
研究设计与样本
- 本文为综述,总结体部介入MRI的技术进展与临床应用,未报告系统检索范围与纳入文献数量。
- 临床诊断MRI于20世纪80年代末引入后不久,MRI引导介入即开始用于临床。
- 早期iMRI应用受限于缺乏专用iMRI磁体、脉冲序列及设备。
诊断标准与关键数值
- iMRI磁体技术在孔径可及性与场强之间取得平衡,配合快速MRI脉冲序列、表面线圈及商用MR兼容设备的发展,推动了临床应用扩展。
- 全球已有多种商用MR兼容穿刺针、导丝、活检及消融设备可用,具体取决于当地监管状态。
临床应用与阅片要点
- 当疾病以MRI显示最佳和/或需优质软组织对比监测治疗时,MRI引导尤为有利。
- iMRI安全至关重要,需介入放射科医生、MR物理师及全体iMRI团队成员密切协作。
- 对MR III区和IV区的人员与设备实施风险限制措施是安全实施的关键。
- 体部iMRI临床应用包括疑难病灶定位、活检、硬化治疗及良恶性肿瘤的冷冻消融与热消融。
局限性
- iMRI检查时间较长,且MR兼容设备缺乏、操作者熟悉度较低、成本增加。
- 本文为综述,未报告系统检索策略、纳入文献数量及证据分级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Clinical use of MRI for guidance during interventional procedures emerged shortly after the introduction of clinical diagnostic MRI in the late 1980s. However, early applications of interventional MRI (iMRI) were limited owing to the lack of dedicated iMRI magnets, pulse sequences, and equipment. During the 3 decades that followed, technologic advancements in iMRI magnets that balance bore access and field strength, combined with the development of rapid MRI pulse sequences, surface coils, and commercially available MR-conditional devices, led to the rapid expansion of clinical iMRI applications, particularly in the field of body iMRI. iMRI offers several advantages, including superior soft-tissue resolution, ease of multiplanar imaging, lack of ionizing radiation, and capability to re-image the same section. Disadvantages include longer examination times, lack of MR-conditional equipment, less operator familiarity, and increased cost. Nonetheless, MRI guidance is particularly advantageous when the disease is best visualized with MRI and/or when superior soft-tissue contrast is needed for treatment monitoring. Safety in the iMRI environment is paramount and requires close collaboration among interventional radiologists, MR physicists, and all other iMRI team members. The implementation of risk-limiting measures for personnel and equipment in MR zones III and IV is key. Various commercially available MR-conditional needles, wires, and biopsy and ablation devices are now available throughout the world, depending on the local regulatory status. As such, there has been tremendous growth in the clinical applications of body iMRI, including localization of difficult lesions, biopsy, sclerotherapy, and cryoablation and thermal ablation of malignant and nonmalignant soft-tissue neoplasms. Online supplemental material is available for this article. ©RSNA, 2021.
引用
- Thompson SM, Gorny KR, Koepsel EMK, et al. Body Interventional MRI for Diagnostic and Interventional Radiologists: Current Practice and Future Prospects. Radiographics. 2021. PMID: 34597216. doi:10.1148/rg.2021210040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。